China Sanjiang Fine Chemicals Company Limited (8C9) News

A buyout will be much lower than some here are thinking. There will be no $50-100B market cap with this ticker. Its anyone guess however, and I stand by my prediction of $10-12 after approval in the UK and a few other things. Spring or summer 2025. We would all benefit if this tech is transferred to

Once this gets through low teens, watch out.

Gooooood moaning shrimpers. How is that uplisting coming?

I never said it will be tomorrow. In my experience most 52 week lows are reached 4-6 months before the buyout. Well before the rumors and news hit the headlines. I have always said this technology will be acquired by BP. It will be in better hands Management wise and the whole pipeline will accelera

Nice volume yesterday.

Karma is the best medicine for people like you 😂

End of another week, of absolutely nothing.
Still no fins, no info. And, FOXO has stolen the show, getting all the interest.
Maybe today we hear something.
GLTA!
RNVA!!$$$????????????????????????

Interesting info. Thanks North.

Captain...Thank you for your continued work over the years... Vascepa was always intended to be a medicine for the masses...To achieve its mission, it must have lower prices in the U.S. in Europe, and worldwide.

Reimbursement in China and a subsequent AG in the U.S (likely occuring

This chit is unreal man. Now I am a baggie

How the World Economic Forum could take firm control of the global financial system
visit - www.cogwriter.com - see link same as above title

FACT:

https://www.justice.gov/criminal/criminal-vns/case/united-states-v-michael-simon-krome

Big Don is going to clobber that goofy looking cackling clown from Canada who couldn't Win her primary. She's only let in 12 million illegal aliens so far and is about to crash the economy. Nice job Border Czar!!

- $AKAN, multiple promos today, tiny 2 mln float! ✅

That’s it, doubled down Lol

Seems it's starting...

https://arcogegr.com/home/

GEGR. We are pleased to complete the requisite requirements with OTC Markets. Updates can commence shortly…

The potential reclassification of cannabis by the DEA, removing it from the schedule-1 drugs list, could significantly impact both medical research and patient access. By allowing the FDA to thoroughly study cannabis for its medical applications, we could see more evidence-based treatments emerge. A

The DEA might reclassify cannabis, removing it from the list of schedule-1 drugs. This would enable the FDA to conduct medical research, and allow insurance companies to assist patients by lowering the overall cost of medical cannabis. This could be achieved through a co-pay system similar to what i

The DEA could remove cannabis from the list of schedule-1 drugs so that the FDA can study it for medical purposes and insurance companies can help patients by reducing the overall cost of medical cannabis through the use of a co-pay similar to picking up a prescription at a pharmacy.

What you post is PBIO news, not Availa Bio. Availa was never a public co, get your facts straight.

In re Availa Bio, Inc., Case No. BK-S-21-14909-NMC (Bankr. D. Nev.
Nov. 24, 2021) [Docket No. 143] (debtor was Nevada corporation with principal assets and place of business in N

2 pct come in pairs
as woodie allen said in a movie
becarefull the giant killers breasts always come in pairs

https://www.youtube.com/watch?v=mr7ZWJJdPV8

nice , going lower still AMD

Just read where they now have Lithium golf carts....can you imagine how fast they are.....or could be....faster than Midget racers ?....Hyper Carts.

Just read where they now have Lithium golf carts....can you imagine how fast they are.....or could be....